RGA Study Predicts GLP-1s Will Lower US Mortality Rate by 3.5% in the Next Two Decades
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Should l Buy RGA?
Source: Newsfilter
Potential Impact on Mortality: By 2045, incretin-based drugs like GLP-1s could reduce mortality in the US by 3.5% under a central scenario, with variations of 8.8% in an optimistic scenario and 1.0% in a pessimistic scenario; similar reductions are expected in the UK, Canada, and Hong Kong.
Age-Related Variations: The greatest mortality improvements are anticipated in individuals aged 45-59, while those aged 85 and older are expected to see the least reduction.
Morbidity and Insured Groups: While there may be positive reductions in cancer incidence, insured groups are likely to experience lower mortality and morbidity reductions compared to the general population due to lower average BMI.
Future of Incretin-Based Therapies: The ongoing investigation into incretin-based therapies for various medical conditions, along with the potential for cost reductions through competition and generics, suggests a promising future for these drugs in improving public health outcomes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RGA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RGA
Wall Street analysts forecast RGA stock price to rise
7 Analyst Rating
5 Buy
1 Hold
1 Sell
Moderate Buy
Current: 224.440
Low
208.00
Averages
242.33
High
275.00
Current: 224.440
Low
208.00
Averages
242.33
High
275.00
About RGA
Reinsurance Group of America, Incorporated is an insurance holding company. The Company is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RGA Reinsurance Company Affirms A+ Rating
- Rating Affirmation: AM Best has affirmed RGA Reinsurance Company and its subsidiaries' Financial Strength Rating of A+ (Superior) and Long-Term Issuer Credit Ratings of 'aa-' (Superior), reflecting their strong balance sheet and operational performance.
- Capital Adequacy: RGA's risk-adjusted capitalization is assessed at the strongest level, indicating compliance with AM Best's standards for financial leverage and liquidity, ensuring a stable financial foundation.
- Market Position: RGA maintains a strong market position in the U.S. and international markets, with approximately half of its revenue derived from international operations, demonstrating the potential for global business expansion as overall premiums have steadily increased in recent years.
- Risk Management: RGA's enterprise risk management framework is continuously enhanced, integrating stress testing and risk monitoring to improve its strategic and operational risk management capabilities, although earnings volatility persists in certain business segments.
See More
RGA Reports Record Q4 2025 Earnings and Strategic Shift
- Record EPS Achievement: RGA reported a record operating EPS of $7.75 for Q4 2025, significantly up from $6.37 in Q3, marking the second consecutive quarter of record earnings, which reflects strong financial performance and market confidence.
- Capital Deployment and Buybacks: The company deployed $2.5 billion into in-force transactions for the full year, with $98 million in Q4 alone, and repurchased $50 million in shares during the quarter, indicating RGA's commitment to maintaining a robust capital base while actively returning value to shareholders.
- Strategic Business Exit: RGA announced its decision to exit the group health care business, which is expected to primarily impact results in 2027, reflecting a strategic focus on more attractive business lines following a comprehensive review of its operations.
- Future Outlook and Growth Targets: Management reiterated its targets of 8% to 10% annual EPS growth and a 13% to 15% return on equity, with an expected capital deployment of around $1.5 billion in 2026, demonstrating confidence in future growth and clarity in strategic planning.
See More
RGA Declares Quarterly Dividend of $0.93 per Share
- Quarterly Dividend Announcement: Reinsurance Group of America (RGA) declares a quarterly dividend of $0.93 per share, consistent with previous distributions, indicating stable cash flow and profitability, which enhances investor confidence.
- Dividend Yield: The forward yield stands at 1.81%, providing investors with a relatively stable return, reflecting the company's attractiveness in the current market environment.
- Payment Schedule: The dividend will be payable on March 3, with a record date of February 17 and an ex-dividend date also on February 17, ensuring shareholders receive timely returns and bolstering their willingness to hold shares.
- Financial Transparency: RGA offers a dividend scorecard, yield chart, and dividend growth information, further enhancing financial transparency and assisting investors in making informed investment decisions.
See More
Reinsurance Group Reports Strong Q4 Earnings Beat
- Earnings Beat: Reinsurance Group's Q4 non-GAAP EPS of $7.75 exceeded expectations by $2.00, indicating robust profitability growth that enhances investor confidence in the company's financial health.
- Significant Revenue Growth: The company reported Q4 revenue of $6.64 billion, a 26.7% year-over-year increase, surpassing market expectations by $390 million, reflecting strong business expansion and demand in the market.
- Strong Net Income: Net income available to RGA shareholders was $6.97 per diluted share, driven by strong investment results and favorable variable investment income, further solidifying the company's financial foundation.
- Share Repurchase Program: The company repurchased $50 million of common shares in Q4, demonstrating management's confidence in future performance while providing additional returns to shareholders.
See More
ScanlanKemperBard Acquires Columbia River Project
- Acquisition Announcement: ScanlanKemperBard, in partnership with RGA ReCap, has announced the acquisition of the Columbia River Collection, a significant industrial project totaling 513,275 square feet, marking a strategic expansion in the industrial real estate sector.
- Project Details: The acquisition encompasses eight buildings, enhancing SKB's market share in the Portland metro area and laying the groundwork for future leasing and development opportunities.
- Strategic Partnership: Collaborating with RGA ReCap not only provides financial backing but also leverages their expertise in real estate investments, thereby enhancing SKB's investment capabilities and competitive positioning in the market.
- Regional Growth Potential: Located along the Columbia River corridor, the project is expected to benefit from economic growth and infrastructure improvements in the Portland area, further driving SKB's long-term revenue growth.
See More
ScanlanKemperBard Acquires Columbia River Project
- Acquisition Scale: ScanlanKemperBard (SKB), in partnership with RGA ReCap, has acquired the Columbia River Collection, a 513,275-square-foot industrial project in the Portland area, marking SKB's third acquisition in 60 days and reflecting confidence in Portland's long-term economic fundamentals.
- Market Dynamics: This transaction highlights a shift in investment activity in Portland, where reduced institutional capital has created attractive opportunities for local investors, with SKB committed to operating through market cycles while focusing on long-term value creation.
- Strategic Location: The Columbia River Collection is situated in one of Portland's most established industrial corridors, benefiting from proximity to regional transportation infrastructure and the core employment base, effectively catering to users under 50,000 square feet and enhancing SKB's competitive edge.
- Long-term Commitment: SKB President Todd Gooding emphasized the company's confidence in Portland due to its talented workforce and strategic location, pledging to continue balancing economic development with resident services in the future.
See More
RGA Reinsurance Company Affirms A+ Rating
- Rating Affirmation: AM Best has affirmed RGA Reinsurance Company and its subsidiaries' Financial Strength Rating of A+ (Superior) and Long-Term Issuer Credit Ratings of 'aa-' (Superior), reflecting their strong balance sheet and operational performance.
- Capital Adequacy: RGA's risk-adjusted capitalization is assessed at the strongest level, indicating compliance with AM Best's standards for financial leverage and liquidity, ensuring a stable financial foundation.
- Market Position: RGA maintains a strong market position in the U.S. and international markets, with approximately half of its revenue derived from international operations, demonstrating the potential for global business expansion as overall premiums have steadily increased in recent years.
- Risk Management: RGA's enterprise risk management framework is continuously enhanced, integrating stress testing and risk monitoring to improve its strategic and operational risk management capabilities, although earnings volatility persists in certain business segments.
See More
RGA Reports Record Q4 2025 Earnings and Strategic Shift
- Record EPS Achievement: RGA reported a record operating EPS of $7.75 for Q4 2025, significantly up from $6.37 in Q3, marking the second consecutive quarter of record earnings, which reflects strong financial performance and market confidence.
- Capital Deployment and Buybacks: The company deployed $2.5 billion into in-force transactions for the full year, with $98 million in Q4 alone, and repurchased $50 million in shares during the quarter, indicating RGA's commitment to maintaining a robust capital base while actively returning value to shareholders.
- Strategic Business Exit: RGA announced its decision to exit the group health care business, which is expected to primarily impact results in 2027, reflecting a strategic focus on more attractive business lines following a comprehensive review of its operations.
- Future Outlook and Growth Targets: Management reiterated its targets of 8% to 10% annual EPS growth and a 13% to 15% return on equity, with an expected capital deployment of around $1.5 billion in 2026, demonstrating confidence in future growth and clarity in strategic planning.
See More
RGA Declares Quarterly Dividend of $0.93 per Share
- Quarterly Dividend Announcement: Reinsurance Group of America (RGA) declares a quarterly dividend of $0.93 per share, consistent with previous distributions, indicating stable cash flow and profitability, which enhances investor confidence.
- Dividend Yield: The forward yield stands at 1.81%, providing investors with a relatively stable return, reflecting the company's attractiveness in the current market environment.
- Payment Schedule: The dividend will be payable on March 3, with a record date of February 17 and an ex-dividend date also on February 17, ensuring shareholders receive timely returns and bolstering their willingness to hold shares.
- Financial Transparency: RGA offers a dividend scorecard, yield chart, and dividend growth information, further enhancing financial transparency and assisting investors in making informed investment decisions.
See More
Reinsurance Group Reports Strong Q4 Earnings Beat
- Earnings Beat: Reinsurance Group's Q4 non-GAAP EPS of $7.75 exceeded expectations by $2.00, indicating robust profitability growth that enhances investor confidence in the company's financial health.
- Significant Revenue Growth: The company reported Q4 revenue of $6.64 billion, a 26.7% year-over-year increase, surpassing market expectations by $390 million, reflecting strong business expansion and demand in the market.
- Strong Net Income: Net income available to RGA shareholders was $6.97 per diluted share, driven by strong investment results and favorable variable investment income, further solidifying the company's financial foundation.
- Share Repurchase Program: The company repurchased $50 million of common shares in Q4, demonstrating management's confidence in future performance while providing additional returns to shareholders.
See More
ScanlanKemperBard Acquires Columbia River Project
- Acquisition Announcement: ScanlanKemperBard, in partnership with RGA ReCap, has announced the acquisition of the Columbia River Collection, a significant industrial project totaling 513,275 square feet, marking a strategic expansion in the industrial real estate sector.
- Project Details: The acquisition encompasses eight buildings, enhancing SKB's market share in the Portland metro area and laying the groundwork for future leasing and development opportunities.
- Strategic Partnership: Collaborating with RGA ReCap not only provides financial backing but also leverages their expertise in real estate investments, thereby enhancing SKB's investment capabilities and competitive positioning in the market.
- Regional Growth Potential: Located along the Columbia River corridor, the project is expected to benefit from economic growth and infrastructure improvements in the Portland area, further driving SKB's long-term revenue growth.
See More
ScanlanKemperBard Acquires Columbia River Project
- Acquisition Scale: ScanlanKemperBard (SKB), in partnership with RGA ReCap, has acquired the Columbia River Collection, a 513,275-square-foot industrial project in the Portland area, marking SKB's third acquisition in 60 days and reflecting confidence in Portland's long-term economic fundamentals.
- Market Dynamics: This transaction highlights a shift in investment activity in Portland, where reduced institutional capital has created attractive opportunities for local investors, with SKB committed to operating through market cycles while focusing on long-term value creation.
- Strategic Location: The Columbia River Collection is situated in one of Portland's most established industrial corridors, benefiting from proximity to regional transportation infrastructure and the core employment base, effectively catering to users under 50,000 square feet and enhancing SKB's competitive edge.
- Long-term Commitment: SKB President Todd Gooding emphasized the company's confidence in Portland due to its talented workforce and strategic location, pledging to continue balancing economic development with resident services in the future.
See More
